🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to test the safety of different doses of speci...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center (Consent and follow-up only)
Start Date
2016-06
Trial ID
NCT02792114
Treatments Being Tested
This is a single-arm, open-label clinical study evaluating the efficacy and...
Status
Withdrawn
Location
Hebei Yanda Ludaopei Hospital
Start Date
2024-11-07
Trial ID
NCT07093086
Treatments Being Tested
This phase 1, single-center, open-label study explores the safety of escala...
Status
Recruiting
Location
University of North Carolina
Start Date
2024-06-27
Trial ID
NCT06347068
Treatments Being Tested
Background: Researchers have found a new way to treat cancer using T cell ...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2022-03-08
Trial ID
NCT05035407
This is a phase I clinical trial to determine the maximum tolerated dose (M...
Status
Recruiting
Location
Rutgers Cancer Institute
Start Date
2022-09-26
Trial ID
NCT05483491
Treatments Being Tested
Multi-center, open-label, first in human Phase 1 study of the safety, toler...
Status
Terminated
Location
Mayo Clinic of Arizona
Start Date
2019-10-10
Trial ID
NCT04025216
Treatments Being Tested
This study will evaluate the safety and tolerability of LYL797, a ROR1-targ...
Status
Terminated
Location
Mayo Clinic
Start Date
2022-03-29
Trial ID
NCT05274451
Treatments Being Tested
An open-label, clinical trial of autologous cMet redirected T cells adminis...
Status
Completed
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2013-04
Trial ID
NCT01837602
Treatments Being Tested
This is a multicenter, open-label, Phase 1/2 master protocol evaluating aut...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07523529